Ilker Yalcin

Ilker Yalcin is the SVP and Head of Biostatistics, Statistical Programming and Data Management at Invivyd since January 2021. Prior to this, Ilker held the position of Vice President in Biostatistics at GSK from March 2019 to December 2020, following the acquisition of TESARO, Inc. by GSK in 2019 where Ilker also served as Vice President in Biostatistics. Before their time at GSK and TESARO, Ilker was the VP in Biostatistics, Data Management and Medical Writing at Synta Pharmaceuticals from 2011 to February 2016. Ilker has a Ph.D. in Statistics from Iowa State University and an MBA in General Management from Indiana University - Kelley School of Business. Prior to their industry roles, Ilker worked at Eli Lilly and Company as a Research Advisor/Group Leader in Lilly Oncology and at the World Health Organization as a Biostatistician/Epidemiologist.